Sign In
Buy CAH
$195.85
+0.97 (+0.498%)
At Close: Jun 03, 2026
4 Stocks to Watch Amid Dental Supplies Industry Challenges
09:46am, Thursday, 12'th Dec 2024
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are BDX, MCK, CAH and MMSI.
Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH
04:01pm, Tuesday, 10'th Dec 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 10'th Dec 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Strength Across Segments to Help CAH Stock Offset OptumRx Headwind?
08:50am, Thursday, 05'th Dec 2024
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, concentrated revenue generation and regulatory setbacks are a concern.
Cardinal Health, Inc. (CAH) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
10:34pm, Tuesday, 03'rd Dec 2024
Cardinal Health, Inc. (NYSE:CAH ) Annual Evercore ISI HealthCONx Healthcare Conference December 3, 2024 1:30 PM ET Company Participants Matt Sims - VP, IR Aaron Alt - CFO Conference Call Participants
Cardinal Health, Inc. (CAH) Citi's 2024 Global Healthcare Conference (Transcript)
10:34am, Tuesday, 03'rd Dec 2024
Cardinal Health, Inc. (NYSE:CAH ) Citi's 2024 Global Healthcare Conference Call December 3, 2024 8:00 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Head, Investor Relation
Should Value Investors Buy Cardinal Health (CAH) Stock?
10:40am, Friday, 29'th Nov 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
CAH Stock Gains on the Launch of Kendall SmartFlow Compression System
12:06pm, Friday, 22'nd Nov 2024
Cardinal Health launches the next generation of the Kendall Compression Series, Kendall SCD SmartFlow Compression System, to aid pain relating to venous stasis.
Cardinal Health launches Kendall SCD SmartFlow™ Compression System
07:30am, Wednesday, 20'th Nov 2024
Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio , Nov. 20, 2024 /PRNewswire/ -- Cardinal Health (
Cardinal Health, Inc. (CAH) UBS Global Healthcare Conference (Transcript)
03:14pm, Friday, 15'th Nov 2024
Cardinal Health, Inc. (NYSE:CAH ) UBS Global Healthcare Conference November 12, 2024 11:00 AM ET Company Participants Matt Sims - Vice President, Investor Relations Aaron Alt - Chief Financial Officer
Cardinal Health Stock Gains Following Two Strategic Acquisitions
11:56am, Wednesday, 13'th Nov 2024
CAH announces two strategic acquisitions to strengthen its multi-specialty and at-Home Solutions businesses.
Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?
10:45am, Wednesday, 13'th Nov 2024
Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
10:45am, Wednesday, 13'th Nov 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Adds the country's leading gastroenterology (GI) management services organization (MSO) to Cardinal Health's Specialty portfolio supporting over 900 physicians in 345 practices in 20 states Adds the c
Cardinal Health buys GI Alliance and Advanced Diabetes Supply Group for about $3.9 bln
09:02pm, Monday, 11'th Nov 2024
Cardinal Health said on Monday it acquired majority stakes in GI Alliance and Advanced Diabetes Supply Group (ADSG) for about $2.8 billion and $1.1 billion each in an all cash deal.
